We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance to help you assess if artificial intelligence (AI) is the right technology for your challenge.
Case study information was collated from African, Middle Eastern, South Asian and Caribbean countries
Results of in-depth assessment of reports of death, arthritis and human exposure following administration of Librela in dogs in the United Kingdom.
Temporary exemption concerning the transportation of UN 2672 ammonia solution in certain containers (ADR M345), which is valid until 31 January 2027.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).